Open AccessGENDER-RELATED ASSESSMENT OF CYCLOSPORINE/PREDNISOLONE/SIROLIMUS INTERACTIONS IN THREE HUMAN LYMPHOCYTE PROLIFERATION ASSAYS1
Author(s) -
Géraldine M. Ferron,
Nancy A. Pyszczynski,
William J. Jusko
Publication year - 1998
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199805150-00011
Subject(s) - mixed lymphocyte reaction , prednisolone , lymphocyte , pharmacology , potency , in vitro , sirolimus , biology , immunology , microbiology and biotechnology , t cell , medicine , immune system , biochemistry
Cyclosporine (CsA), prednisolone (Pred), and sirolimus (Sir) are immunosuppressive compounds inhibiting lymphocyte proliferation at the cytokine gene transcription (CsA and Pred) or signal transduction (Sir) levels.